Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies.
Saved in:
| Title: | Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies. |
|---|---|
| Authors: | Rabbani, Syed Arman1 (AUTHOR), Saini, Manita2,3 (AUTHOR), El-Tanani, Mohamed1,3 (AUTHOR), Kumar, Rakesh3,4 (AUTHOR), Matalka, Ismail1,5 (AUTHOR), El-Tanani, Yahia5,6 (AUTHOR), Sharma, Shrestha1,3 (AUTHOR), Rizzo, Manfredi1,2,6 (AUTHOR) |
| Source: | Pharmaceuticals (14248247). May2026, Vol. 19 Issue 5, p732. 37p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
